Sigilon Therapeutics Inc. (SGTX) NASDAQ
$22.47 - (-)
Market Cap: -
As of 08/10/23 12:00 AM EDT. Market closed.
Sigilon Therapeutics Inc. (SGTX)
NASDAQ
$22.47
- (-)
Market Cap: -
As of 08/10/23 12:00 AM EDT. Market closed.
Add to Portfolio
harnessing the full power of cell therapeutics. cambridge, ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
PRICE CHART FOR SIGILON THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$22.47
Days Range
$22.09 - $23.10
52 week range
- - -
Volume
83,681
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
2,514,498
Open
-
Previous Close
$22.47
Days Range
$22.09 - $23.10
52 week range
- - -
Volume
83,681
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
2,514,498
FINANCIAL STATEMENTS FOR SIGILON THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR SIGILON THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Flagship Ventures Fund V General Partner LLC | 10% Owner | Aug 11, 2023 | Option Exercise | $14.92 | 113,960 | 1,700,283 | 0 | Aug 15, 2023, 04:15 PM |
| Flagship Ventures Fund V General Partner LLC | 10% Owner | Aug 11, 2023 | Option Exercise | $14.92 | 683,760 | 10,201,699 | 0 | Aug 15, 2023, 04:15 PM |
| ELI LILLY & Co | 10% Owner | Aug 11, 2023 | Buy | $14.92 | 1,718,493 | 25,639,916 | 100 | Aug 14, 2023, 04:30 PM |
| Yuan Qing Sarah | CTOO | Jul 27, 2023 | Option Exercise | $19.24 | 2,884 | 55,488 | 2,884 | Jul 27, 2023, 04:21 PM |
| Pontes Josias | CHIEF FINANCIAL OFFICER | Jul 21, 2023 | Option Exercise | $19.24 | 1,444 | 27,783 | 3,254 | Jul 24, 2023, 07:45 PM |
| Vivaldi Coelho Rogerio | PRESIDENT AND CEO | Jul 21, 2023 | Option Exercise | $19.24 | 5,528 | 106,359 | 11,963 | Jul 24, 2023, 07:44 PM |
| RUFFOLO ROBERT R | Director | Jul 01, 2021 | Option Exercise | $0.57 | 6,750 | 3,847 | 6,750 | Jul 02, 2021, 04:16 PM |
| RUFFOLO ROBERT R | Director | Jul 01, 2021 | Sale | $10.36 | 6,750 | 69,930 | 0 | Jul 02, 2021, 04:16 PM |
| ANDERSON DANIEL GRIFFITH | Director | Jun 02, 2021 | Sale | $10.00 | 200,000 | 2,000,000 | 2,022,222 | Jun 04, 2021, 04:15 PM |
| ELI LILLY & Co | 10% Owner | Dec 08, 2020 | Buy | $18.00 | 300,000 | 5,400,000 | 2,744,443 | Dec 10, 2020, 05:00 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Flagship Ventures Fund V General Partner LLC | 10% Owner | 08/11/2023 | 1,700,283 |
| Flagship Ventures Fund V General Partner LLC | 10% Owner | 08/11/2023 | 10,201,699 |
| ELI LILLY & Co | 10% Owner | 08/11/2023 | 25,639,916 |
| Yuan Qing Sarah | CTOO | 07/27/2023 | 55,488 |
| Pontes Josias | CHIEF FINANCIAL OFFICER | 07/21/2023 | 27,783 |
| Vivaldi Coelho Rogerio | PRESIDENT AND CEO | 07/21/2023 | 106,359 |
| RUFFOLO ROBERT R | Director | 07/01/2021 | 3,847 |
| RUFFOLO ROBERT R | Director | 07/01/2021 | 69,930 |
| ANDERSON DANIEL GRIFFITH | Director | 06/02/2021 | 2,000,000 |
| ELI LILLY & Co | 10% Owner | 12/08/2020 | 5,400,000 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR SIGILON THERAPEUTICS INC
STOCK BUYBACKS FOR SIGILON THERAPEUTICS INC
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2020
-49.81%
13Q
12/31/2019
-46.18%
14Q
BUYBACK ANNOUNCEMENT(S) FOR SIGILON THERAPEUTICS INC
LOADING...